{"676854":{"#nid":"676854","#data":{"type":"external_news","title":"Breakthrough in Reprogramming Immune Cells for Anti-Tumor Fight","body":[{"value":"\u003Cp\u003EResearchers at Georgia Tech, led by \u003Ca href=\u0022https:\/\/chemistry.gatech.edu\/\u0022\u003ESchool of Chemistry and Biochemistry\u003C\/a\u003E Professor \u003Ca href=\u0022https:\/\/chemistry.gatech.edu\/people\/mg-finn\u0022\u003EM.G. Finn \u003C\/a\u003E, along with researchers from MIT, revealed a new strategy for enabling immune system mobilization against cancer cells. The work, which appears in ACS Nano, produces exactly the type of anti-tumor immunity needed to function as a tumor vaccine - both prophylactically and therapeutically. Finn\u0027s research, along with two other groups, had previously identified a synthetic DC-SIGN binding group that directed cellular immune responses when used to decorate virus-like particles. But it was unclear whether this method could be utilized as an anticancer vaccine. Collaboration between researchers in the labs at MIT and Georgia Tech demonstrated that in fact, it could.\u003C\/p\u003E","summary":"","format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"\u003Cp\u003EResearchers at Georgia Tech, led by \u003Ca href=\u0022https:\/\/chemistry.gatech.edu\/\u0022\u003ESchool of Chemistry and Biochemistry\u003C\/a\u003E Professor \u003Ca href=\u0022https:\/\/chemistry.gatech.edu\/people\/mg-finn\u0022\u003EM.G. Finn \u003C\/a\u003E, along with researchers from MIT, revealed a new strategy for enabling immune system mobilization against cancer cells. The work, which appears in ACS Nano, produces exactly the type of anti-tumor immunity needed to function as a tumor vaccine - both prophylactically and therapeutically. Finn\u0027s research, along with two other groups, had previously identified a synthetic DC-SIGN binding group that directed cellular immune responses when used to decorate virus-like particles. But it was unclear whether this method could be utilized as an anticancer vaccine. Collaboration between researchers in the labs at MIT and Georgia Tech demonstrated that in fact, it could.\u003C\/p\u003E\u003Cp\u003E\u003Cbr\u003E\u0026nbsp;\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":"","uid":"36609","created_gmt":"2024-09-16 21:02:06","changed_gmt":"2024-09-16 21:02:06","author":"acook304","boilerplate_text":"","field_publication":"","publication":"Mirage News ","field_article_url":"","publication_url":"https:\/\/www.miragenews.com\/breakthrough-in-reprogramming-immune-cells-for-1317426\/","dateline":{"date":"2024-09-16T00:00:00-04:00","iso_date":"2024-09-16T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"groups":[{"id":"1278","name":"College of Sciences"},{"id":"85951","name":"School of Chemistry and Biochemistry"}],"categories":[{"id":"140","name":"Cancer Research"},{"id":"135","name":"Research"},{"id":"134","name":"Student and Faculty"}],"keywords":[{"id":"4896","name":"College of Sciences"},{"id":"166928","name":"School of Chemistry and Biochemistry"},{"id":"280","name":"Cancer research"},{"id":"2070","name":"cancer cell"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[],"email":[],"slides":[],"orientation":[],"userdata":""}}}